Cryo-Cell International (CCEL) Stock Statistics & Valuation Metrics

Cryo-Cell International has a market cap or net worth of $26.90M. The enterprise value is $30.58M.

Cryo-Cell International has 8,055,150 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cryo-Cell International’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.79%.

The current PE Ratio of Cryo-Cell International is ―. Cryo-Cell International’s PEG ratio is 0.02.

In the last 12 months, Cryo-Cell International had revenue of 31.57M and earned -2.43M in profits. Earnings per share was -0.30.

In the last 12 months, operating cash flow was 5.18M and capital expenditures -235.49K, giving a free cash flow of 4.94M billion.

Cryo-Cell International pays an annual dividend of $0.15, resulting in a dividend yield of 11.14%

Cryo-Cell International upcoming earnings date is Jul 9, 2026, TBA (Confirmed).

Cryo-Cell International as a current ratio of 0.59, with Debt / Equity ratio of -13.02%

In the past 12 months, Cryo-Cell International has paid 92.23K in taxes.

Cryo-Cell International EV to EBITDA ratio is 39.51, with an EV/FCF ratio of 8.26.

Cryo-Cell International has $2.90M in cash and marketable securities with $2.40M in debt, giving a net cash position of $504.86K billion.

Gross margin is 77.47%, with operating margin of 15.34%, and net profit margin of -7.70%.

The average price target for Cryo-Cell International is ―, which is 11.43% higher than the current price. The consensus rating is Hold